Connor Clark & Lunn Investment Management Ltd. Purchases 4,330 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Connor Clark & Lunn Investment Management Ltd. grew its position in Utah Medical Products, Inc. (NASDAQ:UTMD) by 72.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,337 shares of the medical instruments supplier’s stock after acquiring an additional 4,330 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.30% of Utah Medical Products worth $692,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Minerva Advisors LLC grew its holdings in shares of Utah Medical Products by 461.8% in the third quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock valued at $2,818,000 after purchasing an additional 34,794 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Utah Medical Products by 7.3% in the 1st quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock worth $13,023,000 after buying an additional 12,402 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Utah Medical Products by 4.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock valued at $1,632,000 after buying an additional 947 shares in the last quarter. Brandes Investment Partners LP lifted its holdings in shares of Utah Medical Products by 66.2% in the 2nd quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock valued at $7,789,000 after acquiring an additional 46,427 shares during the last quarter. Finally, Sequoia Financial Advisors LLC purchased a new position in Utah Medical Products in the second quarter worth about $307,000. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Down 0.0 %

UTMD stock opened at $65.15 on Friday. Utah Medical Products, Inc. has a twelve month low of $63.38 and a twelve month high of $87.21. The stock has a market capitalization of $220.99 million, a price-to-earnings ratio of 15.26 and a beta of 0.08. The firm’s fifty day simple moving average is $65.72 and its two-hundred day simple moving average is $67.13.

Utah Medical Products Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 1.87%. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Monday, December 16th. Utah Medical Products’s dividend payout ratio is presently 28.57%.

Analysts Set New Price Targets

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.